Pharmacy Law

/Pharmacy Law

Client Alert – White House Withdraws Proposed Rebate Rule

Late last week the White House announced that the administration would no longer move forward with its proposed rule that would have ended pharmaceutical rebate safe-harbors for pharmacy benefit managers. We initially addressed the proposed rule in our alert, “The End of the PBM Rebate Safe Harbor? The Stakeholders React.” “Based on careful analysis and [...]

Client Alert – Florida Court Holds the State’s Medical Marijuana Statute Unconstitutional

In a decision that hinged on the use of “and” instead of “or,” Florida’s 1st District Court of Appeals struck down the State’s medical marijuana law, finding that its “vertical integration” scheme fails to comport with the language and intent of the constitutional amendment that initially legalized medical marijuana in 2016. The amendment, approved by [...]

Client Alert – Reverse Pharmaceutical Distributor and Execs Hit with Heavy Penalties for Fraudulent Scheme

A Long Island-based reverse pharmaceutical company, along with two of its top executives, were hit with large fines and ordered to pay some $94 million in restitution by a federal judge following their convictions on a number of charges, including mail fraud, wire fraud, theft of government property, money laundering conspiracy, obstruction of justice, and [...]

Client Alert – FDA Takes First Look at Issues Involved in CBD Regulation

Last week the U.S. Food and Drug Administration (FDA) held a 9-hour public hearing on the issues surrounding its potential regulation of hemp-derived cannabidiol, more commonly referred to as CBD. The panel heard from over 100 speakers, running the gamut from academics, cannabis trade associations and manufacturers, to state officials, members of the agricultural community, [...]

Client Alert – The First, But Maybe Not The Last? Feds Convict Insys Execs in Opioid Racketeering Case

In a first of its kind prosecution, the US Department of Justice has successfully tried and convicted several top pharmaceutical executives for crimes related to the marketing and sale of opioids. The founder of Insys Therapeutics Inc. (Insys), John N. Kapoor, and four other former Insys executives were convicted in Massachusetts of a RICO conspiracy [...]

Client Alert – DOJ Criminal Division Releases Guidance on Evaluation of Corporate Compliance Programs

The Criminal Division of the United States Justice Department (DOJ) recently released a guidance document for its prosecutors as an adjunct to the agency’s Justice Manual. The Manual provides direction to prosecutors on the factors they should consider when conducting an investigation into alleged corporate wrongdoing. The adequacy and effectiveness of a corporation’s compliance program [...]

Client Alert – FTC Accuses Surescripts of Anticompetitive Tactics

The Federal Trade Commission (FTC) has filed suit against Surescripts, LLC, (Surescripts) an Arlington, Virginia based information technology company that supports e-prescription, the electronic transmission of prescriptions between health care organizations and pharmacies, as well as general health information exchange of medical records, for unfair competition. CVS Health, Express Scripts, the National Association of Chain [...]

Feds Take Down $1.2 Billion Telemedicine and DME Fraud Scheme

Twenty-four CEOs, COOs, doctors, and others have been charged in a Medicare fraud scheme that cost the federal health care program over $1 billion. Dubbed “Operation Brace Yourself,” the nationwide takedown was led by a task force comprised of members of the FBI, Office of Inspector General – Health and Human Services, (OIG-HHS) along with [...]

FDA Schedules Hearings on Cannabis Regulation

On April 2, 2019, the U.S. Food and Drug Administration issued a public hearing notice and a press release from the Commissioner to announce FDA’s interest in hearing from cannabis-industry stakeholders on the “safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.” The hearing is set for May 31, [...]

FisherBroyles Welcomes Health & Pharmacy Law Partner Janna King in Houston

HOUSTON — January 2, 2019 — FisherBroyles, LLP, the first and world’s largest cloud-based law firm partnership, is pleased to announce the addition of Janna King as a partner in the firm’s Houston office and Health & Pharmacy Law practice group. “We are thrilled to welcome Janna to FisherBroyles in our Houston office,” said FisherBroyles’ [...]